Global Oral Contraceptive Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Publisher Name :
Date: 17-Dec-2019
No. of pages: 114
Inquire Before Buying

Summary

The global Oral Contraceptive market was xx million US$ in 2018 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2019 and 2025.

This report studies the Oral Contraceptive market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Oral Contraceptive in these regions, from 2014 to 2025, covering

- North America (United States, Canada and Mexico)

- Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

- Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

- South America (Brazil etc.)

- Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

- Pfizer, Inc.

- Bayer AG

- Merck & Co., Inc.

- Janssen Global Services, LLC

- Mankind Pharma Ltd.

- Teva Pharmaceutical Industries Ltd

- Allergan, plc (Actavis)

- Piramal Enterprises Ltd.

- Beijing Zizhu Pharm

By the product type, the market is primarily split into

- Combination

- Progestin Only

- Others

By the end users/application, this report covers the following segments

- Male

- Female

We can also provide the customized separate regional or country-level reports, for the following regions:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Central & South America

- - Brazil

- Middle East & Africa

- - Turkey

- - GCC Countries

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Oral Contraceptive market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Oral Contraceptive market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Oral Contraceptive manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Oral Contraceptive with respect to individual growth trends, future prospects, and their contribution to the total market.

- To project the value and volume of Oral Contraceptive submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Oral Contraceptive are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Contraceptive market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Raw material suppliers

Distributors/traders/wholesalers/suppliers

Regulatory bodies, including government agencies and NGO

Commercial research & development (R&D) institutions

Importers and exporters

Government organizations, research organizations, and consulting firms

Trade associations and industry bodies

End-use industries

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Further breakdown of Oral Contraceptive market on basis of the key contributing countries.

Detailed analysis and profiling of additional market players.

Global Oral Contraceptive Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Table of Contents
1 Oral Contraceptive Market Overview
1.1 Oral Contraceptive Product Overview
1.2 Oral Contraceptive Market Segment by Type
1.2.1 Combination
1.2.2 Progestin Only
1.2.3 Others
1.3 Global Oral Contraceptive Market Size by Type
1.3.1 Global Oral Contraceptive Sales and Growth by Type
1.3.2 Global Oral Contraceptive Sales and Market Share by Type
1.3.3 Global Oral Contraceptive Revenue and Market Share by Type
1.3.4 Global Oral Contraceptive Price by Type
1.4 North America Oral Contraceptive by Type
1.5 Europe Oral Contraceptive by Type
1.6 South America Oral Contraceptive by Type
1.7 Middle East and Africa Oral Contraceptive by Type
2 Global Oral Contraceptive Market Competition by Company
2.1 Global Oral Contraceptive Sales and Market Share by Company (2014-2019)
2.2 Global Oral Contraceptive Revenue and Share by Company (2014-2019)
2.3 Global Oral Contraceptive Price by Company (2014-2019)
2.4 Global Top Players Oral Contraceptive Manufacturing Base Distribution, Sales Area, Product Types
2.5 Oral Contraceptive Market Competitive Situation and Trends
2.5.1 Oral Contraceptive Market Concentration Rate
2.5.2 Global Oral Contraceptive Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Oral Contraceptive Company Profiles and Sales Data
3.1 Pfizer, Inc.
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Oral Contraceptive Product Category, Application and Specification
3.1.3 Pfizer, Inc. Oral Contraceptive Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Bayer AG
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Oral Contraceptive Product Category, Application and Specification
3.2.3 Bayer AG Oral Contraceptive Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Merck & Co., Inc.
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Oral Contraceptive Product Category, Application and Specification
3.3.3 Merck & Co., Inc. Oral Contraceptive Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Janssen Global Services, LLC
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Oral Contraceptive Product Category, Application and Specification
3.4.3 Janssen Global Services, LLC Oral Contraceptive Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Mankind Pharma Ltd.
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Oral Contraceptive Product Category, Application and Specification
3.5.3 Mankind Pharma Ltd. Oral Contraceptive Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Teva Pharmaceutical Industries Ltd
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Oral Contraceptive Product Category, Application and Specification
3.6.3 Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Allergan, plc (Actavis)
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Oral Contraceptive Product Category, Application and Specification
3.7.3 Allergan, plc (Actavis) Oral Contraceptive Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Piramal Enterprises Ltd.
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Oral Contraceptive Product Category, Application and Specification
3.8.3 Piramal Enterprises Ltd. Oral Contraceptive Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Beijing Zizhu Pharm
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Oral Contraceptive Product Category, Application and Specification
3.9.3 Beijing Zizhu Pharm Oral Contraceptive Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
4 Oral Contraceptive Market Status and Outlook by Regions
4.1 Global Oral Contraceptive Market Status and Outlook by Regions
4.1.1 Global Oral Contraceptive Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Europe
4.1.4 Asia-Pacific
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Oral Contraceptive Sales and Revenue by Regions
4.2.1 Global Oral Contraceptive Sales Market Share by Regions (2014-2019)
4.2.2 Global Oral Contraceptive Revenue Market Share by Regions (2014-2019)
4.2.3 Global Oral Contraceptive Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Oral Contraceptive Sales, Revenue, Price and Gross Margin
4.3.1 North America Oral Contraceptive Sales by Countries
4.3.2 United States
4.3.3 Canada
4.3.4 Mexico
4.4 Europe Oral Contraceptive Sales, Revenue, Price and Gross Margin
4.4.1 Europe Oral Contraceptive Sales by Countries
4.4.2 Germany
4.4.3 France
4.4.4 UK
4.4.5 Italy
4.4.6 Russia
4.5 Asia-Pacific Oral Contraceptive Sales, Revenue, Price and Gross Margin
4.5.1 Asia-Pacific Oral Contraceptive Sales by Regions
4.5.2 China
4.5.3 Japan
4.5.4 South Korea
4.5.5 India
4.5.6 Australia
4.5.7 Indonesia
4.5.8 Thailand
4.5.9 Malaysia
4.5.10 Philippines
4.5.11 Vietnam
4.6 South America Oral Contraceptive Sales, Revenue, Price and Gross Margin
4.6.1 South America Oral Contraceptive Sales by Countries
4.6.2 Brazil
4.7 Middle East and Africa Oral Contraceptive Sales, Revenue, Price and Gross Margin
4.7.1 Middle East and Africa Oral Contraceptive Sales by Countries
4.7.2 Turkey
4.7.3 GCC Countries
4.7.4 Egypt
4.7.5 South Africa
5 Oral Contraceptive Application
5.1 Oral Contraceptive Segment by Application
5.1.1 Male
5.1.2 Female
5.2 Global Oral Contraceptive Product Segment by Application
5.2.1 Global Oral Contraceptive Sales by Application
5.2.2 Global Oral Contraceptive Sales and Market Share by Application (2014-2019)
5.3 North America Oral Contraceptive by Application
5.4 Europe Oral Contraceptive by Application
5.5 Asia-Pacific Oral Contraceptive by Application
5.6 South America Oral Contraceptive by Application
5.7 Middle East and Africa Oral Contraceptive by Application
6 Global Oral Contraceptive Market Forecast
6.1 Global Oral Contraceptive Sales, Revenue Forecast (2019-2025)
6.1.1 Global Oral Contraceptive Sales and Growth Rate Forecast (2019-2025)
6.1.2 Global Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Oral Contraceptive Forecast by Regions
6.2.1 North America Oral Contraceptive Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Oral Contraceptive Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Oral Contraceptive Sales and Revenue Forecast (2019-2025)
6.2.4 South America Oral Contraceptive Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Oral Contraceptive Sales and Revenue Forecast (2019-2025)
6.3 Oral Contraceptive Forecast by Type
6.3.1 Global Oral Contraceptive Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Combination Growth Forecast
6.3.3 Progestin Only Growth Forecast
6.4 Oral Contraceptive Forecast by Application
6.4.1 Global Oral Contraceptive Sales Forecast by Application (2019-2025)
6.4.2 Global Oral Contraceptive Forecast in Male
6.4.3 Global Oral Contraceptive Forecast in Female
7 Oral Contraceptive Upstream Raw Materials
7.1 Oral Contraceptive Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Oral Contraceptive Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Sales Channel
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables and Figures
Figure Oral Contraceptive Product Picture
Figure Global Oral Contraceptive Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Oral Contraceptive Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of Combination
Table Major Players of Combination
Figure Global Combination Sales (K Units) and Growth Rate (2014-2019)
Figure Product Picture of Progestin Only
Table Major Players of Progestin Only
Figure Global Progestin Only Sales (K Units) and Growth Rate (2014-2019)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Units) and Growth Rate (2014-2019)
Table Global Oral Contraceptive Sales (K Units) and Growth Rate Comparison by Type (K Units)
Table Global Oral Contraceptive Sales (K Units) by Type (2014-2019) (K Units)
Table Global Oral Contraceptive Sales Share by Type (2014-2019)
Figure Global Oral Contraceptive Sales Market Share by Type (2014-2019)
Figure Global Oral Contraceptive Sales Market Share by Type in 2018
Table Global Oral Contraceptive Revenue (Million USD) by Type (2014-2019)
Table Global Oral Contraceptive Revenue Share by Type (2014-2019)
Figure Global Oral Contraceptive Revenue Share by Type (2014-2019)
Figure Global Oral Contraceptive Revenue Market Share by Type in 2018
Table Global Oral Contraceptive Price (USD/Unit) by Type (2014-2019)
Table North America Oral Contraceptive Sales (USD/Unit) by Type (2014-2019)
Figure North America Oral Contraceptive Sales Market Share by Type in 2018
Table Europe Oral Contraceptive Sales (USD/Unit) by Type (2014-2019)
Figure Europe Oral Contraceptive Sales Market Share by Type in 2018
Table Asia-Pacific Oral Contraceptive Sales (USD/Unit) by Type (2014-2019)
Figure Asia-Pacific Oral Contraceptive Sales Market Share by Type in 2018
Table South America Oral Contraceptive Sales (USD/Unit) by Type (2014-2019)
Figure South America Oral Contraceptive Sales Market Share by Type in 2018
Table Middle East and Africa Oral Contraceptive Sales (USD/Unit) by Type (2014-2019)
Figure Middle East and Africa Oral Contraceptive Sales Market Share by Type in 2018
Table Global Oral Contraceptive Sales (K Units) by Company (2014-2019)
Table Global Oral Contraceptive Sales Share by Company (2014-2019)
Figure Global Oral Contraceptive Sales Share by Company in 2018
Table Global Oral Contraceptive Revenue (Million US$) by Company (2014-2019)
Table Global Oral Contraceptive Revenue Share by Company (2014-2019)
Figure Global Oral Contraceptive Revenue Share by Company in 2018
Table Global Market Oral Contraceptive Average Price (USD/Unit) by Company (2014-2019)
Table Global Oral Contraceptive Top Company Manufacturing Base Distribution and Sales Area
Table Global Oral Contraceptive Top Manufacturers Product Category
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) 15
Figure Global Oral Contraceptive Market Share of Top 5 Company
Figure Global Oral Contraceptive Market Share of Top 10 Company
Table Mergers & Acquisitions, Expansion Plans
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. Oral Contraceptive Product Category, Application and Specification
Table Pfizer, Inc. Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Pfizer, Inc. Description and Business Overview
Table Bayer AG Basic Information List
Table Bayer AG Oral Contraceptive Product Category, Application and Specification
Table Bayer AG Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Bayer AG Description and Business Overview
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Oral Contraceptive Product Category, Application and Specification
Table Merck & Co., Inc. Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Merck & Co., Inc. Description and Business Overview
Table Janssen Global Services, LLC Basic Information List
Table Janssen Global Services, LLC Oral Contraceptive Product Category, Application and Specification
Table Janssen Global Services, LLC Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Janssen Global Services, LLC Description and Business Overview
Table Mankind Pharma Ltd. Basic Information List
Table Mankind Pharma Ltd. Oral Contraceptive Product Category, Application and Specification
Table Mankind Pharma Ltd. Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Mankind Pharma Ltd. Description and Business Overview
Table Teva Pharmaceutical Industries Ltd Basic Information List
Table Teva Pharmaceutical Industries Ltd Oral Contraceptive Product Category, Application and Specification
Table Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Teva Pharmaceutical Industries Ltd Description and Business Overview
Table Allergan, plc (Actavis) Basic Information List
Table Allergan, plc (Actavis) Oral Contraceptive Product Category, Application and Specification
Table Allergan, plc (Actavis) Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Allergan, plc (Actavis) Description and Business Overview
Table Piramal Enterprises Ltd. Basic Information List
Table Piramal Enterprises Ltd. Oral Contraceptive Product Category, Application and Specification
Table Piramal Enterprises Ltd. Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Piramal Enterprises Ltd. Description and Business Overview
Table Beijing Zizhu Pharm Basic Information List
Table Beijing Zizhu Pharm Oral Contraceptive Product Category, Application and Specification
Table Beijing Zizhu Pharm Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Beijing Zizhu Pharm Description and Business Overview
Table Global Oral Contraceptive Market Size Comparison by Regions (2014-2025) (K Units) & (Million US$)
Figure North America Oral Contraceptive Revenue (Million USD) and Growth Rate (2014-2025)
Figure Asia-Pacific Oral Contraceptive Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Oral Contraceptive Revenue (Million USD) and Growth Rate (2014-2025)
Figure South America Oral Contraceptive Revenue (Million USD) and Growth Rate (2014-2025)
Figure Middle East and Africa Oral Contraceptive Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Oral Contraceptive Sales (K Units) by Regions (2014-2019)
Table Global Oral Contraceptive Sales Market Share by Regions (2014-2019)
Figure Global Oral Contraceptive Sales Market Share by Regions (2014-2019)
Figure 2018 Global Oral Contraceptive Sales Market Share by Regions
Table Global Oral Contraceptive Revenue (Million USD) by Regions (2014-2019)
Table Global Oral Contraceptive Revenue Market Share by Regions (2014-2019)
Figure Global Oral Contraceptive Revenue Market Share by Regions (2014-2019)
Figure 2018 Global Oral Contraceptive Revenue Market Share by Regions
Table Global Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure North America Oral Contraceptive Sales Growth Rate
Table North America Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure United States Oral Contraceptive Sales (K Units)(2014-2019)
Figure United States Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Canada Oral Contraceptive Sales (K Units)(2014-2019)
Figure Canada Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Mexico Oral Contraceptive Sales (K Units)(2014-2019)
Figure Mexico Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Europe Oral Contraceptive Sales Growth Rate
Table Europe Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Germany Oral Contraceptive Sales (K Units)(2014-2019)
Figure Germany Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure France Oral Contraceptive Sales (K Units)(2014-2019)
Figure France Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure UK Oral Contraceptive Sales (K Units)(2014-2019)
Figure UK Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Italy Oral Contraceptive Sales (K Units)(2014-2019)
Figure Italy Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Russia Oral Contraceptive Sales (K Units)(2014-2019)
Figure Russia Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Oral Contraceptive Sales Growth Rate
Table Asia-Pacific Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure China Oral Contraceptive Sales (K Units)(2014-2019)
Figure China Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Japan Oral Contraceptive Sales (K Units)(2014-2019)
Figure Japan Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure South Korea Oral Contraceptive Sales (K Units)(2014-2019)
Figure South Korea Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure India Oral Contraceptive Sales (K Units)(2014-2019)
Figure India Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Australia Oral Contraceptive Sales (K Units)(2014-2019)
Figure Australia Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Indonesia Oral Contraceptive Sales (K Units)(2014-2019)
Figure Indonesia Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Thailand Oral Contraceptive Sales (K Units)(2014-2019)
Figure Thailand Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Malaysia Oral Contraceptive Sales (K Units)(2014-2019)
Figure Malaysia Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Philippines Oral Contraceptive Sales (K Units)(2014-2019)
Figure Philippines Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Vietnam Oral Contraceptive Sales (K Units)(2014-2019)
Figure Vietnam Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure South America Oral Contraceptive Sales Growth Rate
Table South America Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Brazil Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Brazil Oral Contraceptive Sales (K Units)(2014-2019)
Figure Middle East and Africa Oral Contraceptive Sales Growth Rate
Table Middle East and Africa Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Turkey Oral Contraceptive Sales (K Units)(2014-2019)
Figure Turkey Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure GCC Countries Oral Contraceptive Sales (K Units)(2014-2019)
Figure GCC Countries Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Egypt Oral Contraceptive Sales (K Units)(2014-2019)
Figure Egypt Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure South Africa Oral Contraceptive Sales (K Units)(2014-2019)
Figure South Africa Oral Contraceptive Revenue (Million USD)(2014-2019)
Figure Male Examples
Figure Female Examples
Table Global Oral Contraceptive Sales (K Units) Comparison by Application (2014-2025)
Table Global Oral Contraceptive Sales (K Units) by Application (2014-2019)
Table Global Oral Contraceptive Sales Share by Application (2014-2019)
Figure Global Oral Contraceptive Sales Market Share by Application (2014-2019)
Figure Global Oral Contraceptive Sales Market Share by Application in 2018
Figure Global Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Global Oral Contraceptive Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Oral Contraceptive Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Oral Contraceptive Sales Market Share Forecast by Regions (2019-2025)
Figure North America Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure North America Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Figure Europe Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Europe Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Figure Asia-Pacific Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Asia-Pacific Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Figure China Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure China Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Figure Japan Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Japan Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Figure South Korea Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure South Korea Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Figure India Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure India Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Figure Australia Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Australia Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Figure Indonesia Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Indonesia Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Figure South America Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure South America Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Figure Middle East & Africa Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Middle East & Africa Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Figure Turkey Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Turkey Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Figure GCC Countries Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure GCC Countries Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Figure Egypt Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Egypt Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Figure South Africa Oral Contraceptive Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure South Africa Oral Contraceptive Revenue and Growth Rate Forecast (2019-2025)
Table Global Oral Contraceptive Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Oral Contraceptive Sales Market Share Forecast by Type (2019-2025)
Table Global Oral Contraceptive Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Oral Contraceptive Revenue Market Share Forecast by Type (2019-2025)
Figure Combination Sales Growth Forecast
Figure Progestin Only Sales Growth Forecast
Table Global Oral Contraceptive Sales (K Units) Forecast by Application (2019-2025)
Figure Global Oral Contraceptive Sales Forecast by Application (2019-2025)
Figure Global Oral Contraceptive Sales (K Units) Forecast in Male
Figure Global Oral Contraceptive Sales (K Units) Forecast in Female
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Oral Contraceptive Manufacturing Cost Structure
Figure Oral Contraceptive Industrial Chain Analysis
Table Distributors List
Table Oral Contraceptive Downstream Customers
Table Research Programs/Design for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
  • Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
  • Global Contraceptives Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
  • Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
  • Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
  • Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139
    Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
  • Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
  • Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
  • Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs